SALTO - Epidemiological Study on Compliance and Treatment Satisfaction

Bayer

Status: Completed

Conditions: Thromboembolism

Treatments: Behavioral: No Drug

Study type: Observational

Funder types: Industry

Identifiers

NCT00911001

NN0811ES

14343

Details and patient eligibility

About

Patients that are on total knee/hip replacement initiate prophylaxis treatment on the hospital ground. Once they leave the hospital, as outpatients they continue with the treatment at least during two consecutive weeks. Patients will be instructed to follow treatment recommendations (either LMWH or oral treatment, at physician discretion) and to come back to the surgeon after that period. At that visit, the Treatment Satisfaction Questionaire with Medication (TSQM) test as well as the Moriski-Green Questionaire (measures compliance with medication) will be answer by the patient. TSQM is an self administered validated scale (validated also in spanish) that measures in a generic way the treatment satisfaction to a treatment. Morinski-Green test will be used to measure the compliance degree on medication.

Enrollment: 480 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients in antithrombotic prophylaxis treatment after total knee/hip replacement. This is an epidemiological study where the patients to be included will be those that are treated with antithrombotics as out-patients in real life conditions.

Exclusion criteria

• Patients who has been previously treated with injectable antithrombotic treatments.
• Diabetic patients treated with insulin.
• Patients who do not sign Informed Consent Form.

Trial design

480 participants in 1 patient group

Group 1

Treatment:

Behavioral: No Drug